PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma
Programmed cell death ligand 1 (PD-L1) is an immune checkpoint molecule that attenuates the immune response. PD-L1 contributes to failed antitumor immunity; thereby, blockade of PD-L1 with monoclonal antibody ...
Source: Maxillofacial Plastic and Reconstructive Surgery - Category: ENT & OMF Authors: Itaru Tojyo, Yukari Shintani, Takashi Nakanishi, Kenjiro Okamoto, Yukihiro Hiraishi, Shigeyuki Fujita, Mayu Enaka, Fuyuki Sato and Yasuteru Muragaki Tags: Research Source Type: research
More News: Cancer & Oncology | Carcinoma | ENT & OMF | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma